ADMA Biologics
ADMA
ADMA
72 hedge funds and large institutions have $165M invested in ADMA Biologics in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 67 → 72 (+5)
3.62% more ownership
Funds ownership: 59.06% → 62.69% (+3.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
72
Holding in Top 10
1
Calls
$495K
Puts
$230K
Top Buyers
| 1 | +$5.55M | |
| 2 | +$3.31M | |
| 3 | +$1.83M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$1.61M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.5M |
Top Sellers
| 1 | -$2.65M | |
| 2 | -$2.63M | |
| 3 | -$2.27M | |
| 4 |
JG
Jefferies Group
New York
|
-$1.18M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.15M |